Articles by Amy Ritter, PhD - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

Articles by Amy Ritter, PhD

Pfizer Settles Off-Label Promotion Charges

Dec 17, 2012

Pfizer has agreed to pay $55 million plus interest to settle charges that Wyeth (acquired by Pfizer in October, 2009) improperly promoted the drug Protonix (pantoprazole).

Biogen Idec and Isis Pharmaceuticals To Collaborate On Antisense Programs

Dec 10, 2012

Biogen Idec and Isis Pharmaceuticals announced that they have entered into a global collaboration agreement under which the companies will discover and develop antisense drugs against three undisclosed targets to treat neurological or neuromuscular disorders.

Lilly Releases Corporate Responsibility Update

Dec 3, 2012

Eli Lilly released its annual report containing updates on progress and new initiatives in corporate responsibility.

Discovery Pipeline: Understanding Cellular Reprogramming

Recent research examines the sequence of events underlying cellular reprogramming, which may aid in better control of the production of induced pluripotent stem cells.
Dec 1, 2012

Recent research examines the sequence of events underlying cellular reprogramming, which may aid in better control of the production of induced pluripotent stem cells.

Job Security in a Changing Biopharma Environment

Results from the 2012 employment survey.
Dec 1, 2012

Results from the 2012 employment survey.

First Seasonal Influenza Vaccine Produced in Cell Culture Approved in US

Nov 26, 2012

Novartis announced that it has received FDA approval for a seasonal influenza vaccine produced in cell culture, the first seasonal vaccine produced by this method to be approved in the US.

FDA Adopts Final Version of Q11 Guidance

Nov 20, 2012

FDA announced the availability of the guidance, “Q11 Development and Manufacture of Drug Substances,†in the Nov. 20, 2011 edition of the Federal Register.

Legislators Request Info on Link Between Drug Shortages and Increased Reliance on Compounding

Nov 19, 2012

House Democrats have requested the Government Accountability Office (GAO) to conduct an inquiry into factors leading to an increased reliance on compounded products.

Raid Captures 82 Million Doses of Counterfeit Drugs in Africa

Nov 12, 2012

An operation spanning 16 African countries and conducted by the World Customs Organization (WCO) in partnership with the Institute of Research against Counterfeit Medicines (IRACM) led to the seizure of more than 82 million doses of counterfeit medicines.

ADVERTISEMENT

ADVERTISEMENT

Click here